GDTC
Price
$1.87
Change
+$0.03 (+1.63%)
Updated
Aug 7, 10:30 AM (EDT)
Capitalization
21.23M
99 days until earnings call
GRCE
Price
$2.91
Change
-$0.06 (-2.02%)
Updated
Aug 7, 10:35 AM (EDT)
Capitalization
41.07M
Interact to see
Advertisement

GDTC vs GRCE

Header iconGDTC vs GRCE Comparison
Open Charts GDTC vs GRCEBanner chart's image
CytoMed Therapeutics
Price$1.87
Change+$0.03 (+1.63%)
VolumeN/A
Capitalization21.23M
Grace Therapeutics
Price$2.91
Change-$0.06 (-2.02%)
Volume$724
Capitalization41.07M
GDTC vs GRCE Comparison Chart in %
Loading...
GDTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GRCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GDTC vs. GRCE commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GDTC is a Hold and GRCE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (GDTC: $1.84 vs. GRCE: $2.97)
Brand notoriety: GDTC and GRCE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GDTC: 25% vs. GRCE: 86%
Market capitalization -- GDTC: $21.23M vs. GRCE: $41.07M
GDTC [@Biotechnology] is valued at $21.23M. GRCE’s [@Biotechnology] market capitalization is $41.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GDTC’s FA Score shows that 0 FA rating(s) are green whileGRCE’s FA Score has 0 green FA rating(s).

  • GDTC’s FA Score: 0 green, 5 red.
  • GRCE’s FA Score: 0 green, 5 red.
According to our system of comparison, GRCE is a better buy in the long-term than GDTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GDTC’s TA Score shows that 4 TA indicator(s) are bullish while GRCE’s TA Score has 3 bullish TA indicator(s).

  • GDTC’s TA Score: 4 bullish, 5 bearish.
  • GRCE’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, GDTC is a better buy in the short-term than GRCE.

Price Growth

GDTC (@Biotechnology) experienced а -2.79% price change this week, while GRCE (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.67%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +14.10%.

Reported Earning Dates

GDTC is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+2.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GRCE($41.1M) has a higher market cap than GDTC($21.2M). GRCE YTD gains are higher at: -20.588 vs. GDTC (-45.882).
GDTCGRCEGDTC / GRCE
Capitalization21.2M41.1M52%
EBITDAN/A-16.72M-
Gain YTD-45.882-20.588223%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A11.1M-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
GRCE: Fundamental Ratings
GRCE
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
48
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
7

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GDTCGRCE
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
85%
Bullish Trend 18 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
GDTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GRCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MARA15.890.27
+1.73%
MARA Holdings Inc
LVTX1.530.03
+1.66%
LAVA Therapeutics NV
SCHW96.710.27
+0.28%
Charles Schwab Corp (The)
REFI13.23-0.07
-0.53%
Chicago Atlantic Real Estate Finance
FLNG25.36-0.19
-0.74%
FLEX LNG Ltd

GDTC and

Correlation & Price change

A.I.dvisor tells us that GDTC and CYCN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GDTC and CYCN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
+2.22%
CYCN - GDTC
30%
Poorly correlated
-17.30%
CVKD - GDTC
29%
Poorly correlated
+0.46%
QSI - GDTC
28%
Poorly correlated
-4.86%
ADIL - GDTC
27%
Poorly correlated
-4.88%
GRCE - GDTC
27%
Poorly correlated
+0.17%
More

GRCE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRCE has been loosely correlated with IMVT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GRCE jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRCE
1D Price
Change %
GRCE100%
+0.17%
IMVT - GRCE
38%
Loosely correlated
-3.33%
SLNO - GRCE
38%
Loosely correlated
-0.54%
CYTK - GRCE
36%
Loosely correlated
-2.82%
SCNI - GRCE
31%
Poorly correlated
N/A
ATAI - GRCE
30%
Poorly correlated
+1.21%
More